Anne L. Holleran

Array ( [id] => 6228810 [patent_doc_number] => 20100183548 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-22 [patent_title] => 'TWEAK RECEPTOR' [patent_app_type] => utility [patent_app_number] => 12/751912 [patent_app_country] => US [patent_app_date] => 2010-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 19524 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0183/20100183548.pdf [firstpage_image] =>[orig_patent_app_number] => 12751912 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6339985 [patent_doc_number] => 20100247533 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-30 [patent_title] => 'TREATMENT WITH A HUMANIZED ANTI-EGFR IgG1 ANTIBODY AND IRINOTECAN' [patent_app_type] => utility [patent_app_number] => 12/748506 [patent_app_country] => US [patent_app_date] => 2010-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 15556 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0247/20100247533.pdf [firstpage_image] =>[orig_patent_app_number] => 12748506 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6195537 [patent_doc_number] => 20110027291 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-03 [patent_title] => 'METHODS, SYSTEMS AND PRODUCTS FOR PREDICTING RESPONSE OF TUMOR CELLS TO A THERAPEUTIC AGENT AND TREATING A PATIENT ACCORDING TO THE PREDICTED RESPONSE' [patent_app_type] => utility [patent_app_number] => 12/707521 [patent_app_country] => US [patent_app_date] => 2010-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 40355 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 27 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20110027291.pdf [firstpage_image] =>[orig_patent_app_number] => 12707521 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6538388 [patent_doc_number] => 20100221742 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-02 [patent_title] => 'NOVEL CANCER ASSOCIATED ANTIBODIES AND THEIR USE IN CANCER DIAGNOSIS' [patent_app_type] => utility [patent_app_number] => 12/705117 [patent_app_country] => US [patent_app_date] => 2010-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4113 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0221/20100221742.pdf [firstpage_image] =>[orig_patent_app_number] => 12705117 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7586364 [patent_doc_number] => 20110280874 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-17 [patent_title] => 'MODULATING ANGIOGENESIS' [patent_app_type] => utility [patent_app_number] => 13/145877 [patent_app_country] => US [patent_app_date] => 2010-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 34845 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0280/20110280874.pdf [firstpage_image] =>[orig_patent_app_number] => 13145877 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6292945 [patent_doc_number] => 20100239653 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-23 [patent_title] => 'PHARMACEUTICAL PREPARATIONS AND METHODS FOR INHIBITING TUMORS' [patent_app_type] => utility [patent_app_number] => 12/692225 [patent_app_country] => US [patent_app_date] => 2010-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 25982 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0239/20100239653.pdf [firstpage_image] =>[orig_patent_app_number] => 12692225 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7586356 [patent_doc_number] => 20110280866 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-17 [patent_title] => 'ANTI-CD 160 MONOCLONAL ANTIBODIES AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/145509 [patent_app_country] => US [patent_app_date] => 2010-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 5399 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0280/20110280866.pdf [firstpage_image] =>[orig_patent_app_number] => 13145509 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6447162 [patent_doc_number] => 20100105064 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-29 [patent_title] => 'METHOD OF SCREENING TEST SUBSTANCES FOR TREATING OR PREVENTING A DISEASE MEDIATED BY PLASMA CELLS' [patent_app_type] => utility [patent_app_number] => 12/649849 [patent_app_country] => US [patent_app_date] => 2009-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 11948 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20100105064.pdf [firstpage_image] =>[orig_patent_app_number] => 12649849 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6270986 [patent_doc_number] => 20100255019 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-07 [patent_title] => 'Ii-KEY/HER-2/NEU HYBRID CANCER VACCINE' [patent_app_type] => utility [patent_app_number] => 12/643509 [patent_app_country] => US [patent_app_date] => 2009-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 9338 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0255/20100255019.pdf [firstpage_image] =>[orig_patent_app_number] => 12643509 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6625573 [patent_doc_number] => 20100172832 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-08 [patent_title] => 'DIAGNOSIS AND TREATMENT OF MALIGNANT NEOPLASMS' [patent_app_type] => utility [patent_app_number] => 12/643046 [patent_app_country] => US [patent_app_date] => 2009-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 18638 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0172/20100172832.pdf [firstpage_image] =>[orig_patent_app_number] => 12643046 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10863453 [patent_doc_number] => 08889143 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-11-18 [patent_title] => 'Ii-key/HER-2/neu hybrid cancer vaccine' [patent_app_type] => utility [patent_app_number] => 12/635656 [patent_app_country] => US [patent_app_date] => 2009-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 18 [patent_no_of_words] => 9885 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 124 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12635656 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6361632 [patent_doc_number] => 20100087621 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-08 [patent_title] => 'IMMUNE REACTIVITY TO HER-2/NEU PROTEIN FOR DIAGNOSIS AND TREATMENT OF MALIGNANCIES IN WHICH THE HER-2/NEU ONCOGENE IS ASSOCIATED' [patent_app_type] => utility [patent_app_number] => 12/629651 [patent_app_country] => US [patent_app_date] => 2009-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 18016 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0087/20100087621.pdf [firstpage_image] =>[orig_patent_app_number] => 12629651 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6235323 [patent_doc_number] => 20100267027 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-21 [patent_title] => 'HER-2 BINDING ANTAGONISTS' [patent_app_type] => utility [patent_app_number] => 12/628272 [patent_app_country] => US [patent_app_date] => 2009-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 16374 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0267/20100267027.pdf [firstpage_image] =>[orig_patent_app_number] => 12628272 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6574698 [patent_doc_number] => 20100129367 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-27 [patent_title] => 'HUMAN BETA-GLUCURONIDASE MUTANTS WITH ELEVATED ENZYMATIC ACTIVITY UNDER PHYSIOLOGICAL CONDITIONS AND METHOD FOR IDENTIFYING SUCH' [patent_app_type] => utility [patent_app_number] => 12/625795 [patent_app_country] => US [patent_app_date] => 2009-11-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 11479 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0129/20100129367.pdf [firstpage_image] =>[orig_patent_app_number] => 12625795 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6268345 [patent_doc_number] => 20100298545 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-25 [patent_title] => 'EphA2 AGONISTIC MONOCLONAL ANTIBODIES AND METHODS OF USE THEREOF' [patent_app_type] => utility [patent_app_number] => 12/626016 [patent_app_country] => US [patent_app_date] => 2009-11-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 36486 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0298/20100298545.pdf [firstpage_image] =>[orig_patent_app_number] => 12626016 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6317136 [patent_doc_number] => 20100112603 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-06 [patent_title] => 'METHOD FOR PREDICTING THE RESPONSE TO A TREATMENT' [patent_app_type] => utility [patent_app_number] => 12/624443 [patent_app_country] => US [patent_app_date] => 2009-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 15651 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0112/20100112603.pdf [firstpage_image] =>[orig_patent_app_number] => 12624443 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6635505 [patent_doc_number] => 20100226887 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-09 [patent_title] => 'BETA-2-GLYCOPROTEIN 1 IS AN INHIBITOR OF ANGIOGENESIS' [patent_app_type] => utility [patent_app_number] => 12/622698 [patent_app_country] => US [patent_app_date] => 2009-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 31301 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0226/20100226887.pdf [firstpage_image] =>[orig_patent_app_number] => 12622698 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6280434 [patent_doc_number] => 20100119521 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-13 [patent_title] => 'COMPOSITIONS AND METHODS FOR TREATING CANCER BY MODULATING HER-2 AND EGF RECEPTORS' [patent_app_type] => utility [patent_app_number] => 12/606094 [patent_app_country] => US [patent_app_date] => 2009-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 24267 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20100119521.pdf [firstpage_image] =>[orig_patent_app_number] => 12606094 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10130267 [patent_doc_number] => 09164097 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-10-20 [patent_title] => 'Formulations targeting IGFBP7 for diagnosis and therapy of cancer' [patent_app_type] => utility [patent_app_number] => 13/124314 [patent_app_country] => US [patent_app_date] => 2009-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 9447 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13124314 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5953165 [patent_doc_number] => 20110033867 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-10 [patent_title] => 'Use of biomarkers for detecting ovarian cancer' [patent_app_type] => utility [patent_app_number] => 12/586462 [patent_app_country] => US [patent_app_date] => 2009-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 22913 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 22 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0033/20110033867.pdf [firstpage_image] =>[orig_patent_app_number] => 12586462 [rel_patent_id] =>[rel_patent_doc_number] =>)